People with chronic obstructive pulmonary disease (COPD) are at increased risk from coronavirus.

The British Thoracic Society (BTS) has developed COPD admission and discharge care bundles with the aim of improving care, helping patients manage their condition at home, and reducing readmissions.

Acute hospital trusts are being encouraged to deliver all appropriate elements of the COPD discharge care bundle for patients admitted to hospital with COPD. The National Patient Safety Improvement Programmes (NatPatSIPs) have been supporting trusts to adopt the care bundle, through the 15 Patient Safety Collaboratives (PSCs) in England, hosted by Academic Health Science Networks.

While the current focus on COVID-19 continues, PSCs are temporarily pausing work to actively promote the COPD discharge bundle. However, they will remain available to provide any support that organisations require.

Organisations providing updates during COVID-19

Follow this link for more information on patient safety during COVID-19.

  • Report: Forging a more equitable future through Patient and Public Involvement and Engagement

    The need for fast-paced innovation in healthcare is widely acknowledged. And ensuring that healthcare innovation is shaped by the people it serves remains a pressing priority – one made all the more evident by the growing emphasis on health equity in the 10 Year Health Plan. Patient voices are often cited as central to healthcare [...]

  • 2025 NHS Innovation Accelerator Fellows  

    The NHS Innovation Accelerator (NIA) has revealed its 2025 cohort of Fellows. As the NIA celebrates a decade of helping to drive innovation in the NHS, this year’s cohort aligns with the Government’s three priorities: supporting the transition from analogue to digital, sickness to prevention and hospital to home.  The 28 new Fellows will benefit [...]

  • Launch of new “game changing” guide to tackle overprescribing and support Government’s shifts to prevention and community

    A new guide aimed at helping primary care organisations and integrated care boards understand and address problematic polypharmacy has been launched by the Health Innovation Network as part of its national Polypharmacy Programme. Developed in response to a clear need identified by primary care and prescribing colleagues, this essential resource provides practical, evidence-based strategies to [...]